Literature DB >> 436296

Decreased cerebrospinal fluid concentration of free phenylacetic acid in depressive illness.

M Sandler, C R Ruthven, B L Goodwin, A Coppen.   

Abstract

Cerebrospinal fluid free phenylacetic acid concentration in a series of depressive patients was significantly lower than values in control subjects. This acid derives from phenylethylamine and the findings may reflect a decrease in its brain formation. Such a deficit may be related to other recent observations of a decrease in urinary output of the major metabolites of the "trace amines", octopamine and tyramine: phenylethylamine is thought to be the precursor of these "trace amines".

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 436296     DOI: 10.1016/0009-8981(79)90261-4

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  5 in total

Review 1.  Receptors of mammalian trace amines.

Authors:  Anita H Lewin
Journal:  AAPS J       Date:  2006-03-10       Impact factor: 4.009

2.  Urinary 4-hydroxy-3-methoxyphenylglycol is not a predictor for clinical response to amitriptyline in depressive illness.

Authors:  A Coppen; V A Rama Rao; C R Ruthven; B L Goodwin; M Sandler
Journal:  Psychopharmacology (Berl)       Date:  1979-06-28       Impact factor: 4.530

3.  Precursors and metabolites of phenylethylamine, m and p-tyramine and tryptamine in human lumbar and cisternal cerebrospinal fluid.

Authors:  S N Young; B A Davis; S Gauthier
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-07       Impact factor: 10.154

4.  Phenylacetic acid in human body fluids: high correlation between plasma and cerebrospinal fluid concentration values.

Authors:  M Sandler; C R Ruthven; B L Goodwin; A Lees; G M Stern
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-04       Impact factor: 10.154

5.  Neuropharmacological and neurochemical properties of N-(2-cyanoethyl)-2-phenylethylamine, a prodrug of 2-phenylethylamine.

Authors:  G B Baker; R T Coutts; T S Rao
Journal:  Br J Pharmacol       Date:  1987-10       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.